TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $109.94M2011: $97.99M2012: $125.54M2013: $347.10M2014: $248.01M2015: $337.58M2016: $383.36M2017: $315.62M2018: $155.81M2019: $122.93M2020: $235.84M2021: $444.65M2022: $352.74M2023: $465.63M2024: $792.34M2025: $582.98M$582.98M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$582.98M-26.4%
2024$792.34M+70.2%
2023$465.63M+32.0%
2022$352.74M-20.7%
2021$444.65M+88.5%
2020$235.84M+91.8%
2019$122.93M-21.1%
2018$155.81M-50.6%
2017$315.62M-17.7%
2016$383.36M+13.6%
2015$337.58M+36.1%
2014$248.01M-28.5%
2013$347.10M+176.5%
2012$125.54M+28.1%
2011$97.99M-10.9%
2010$109.94M—